Reveal Mobi Pro (Photo: KA Imaging)
April 14, 2026 — KA Imaging is seeing continued adoption of its X-ray technology across new regions, with recent milestones reflecting growing clinical use worldwide.
In Asia-Pacific, the company secured Irradiating Apparatus License in Hong Kong to bring its Reveal Mobi Pro and Mobi Lite mobile X-ray systems into the market. In Australia, the Reveal Mobi Pro is now cleared for sale following regulatory review.
“Across regions, we’re seeing consistent interest in approaches that add information to standard X-ray without adding complexity,” said Charlie Hicks, VP Global Medical Sales. “That’s what is driving adoption of our SpectralDR technology, particularly in mobile and bedside settings.”
Alongside clinical growth, KA Imaging is also expanding in research. A new partnership with Scintica will bring its 3D X-ray imaging platform to more preclinical and biomedical research groups across North America, supporting work in areas such as materials and life sciences.
“By bringing together phase-contrast imaging with inCiTe and high-resolution amorphous selenium technology with BrillianSe, we’re helping advance research and science,” said Jim Harp, Vice President of NDT Sales & Business Development.
These developments come as the company continues to work with partners on new applications of X-ray imaging, including early-stage efforts in space-based research.
For KA Imaging, the momentum reflects a broader shift in how X-ray is being used — not as a fixed, standalone tool, but as part of a wider set of decisions across care pathways and research environments.
In clinical settings, this means imaging is moving closer to where decisions are made, whether at the bedside, in the emergency department, or in outpatient workflows, where speed and context matter. Rather than serving only as a first step before more advanced imaging, X-ray is increasingly used to guide next steps, support triage, and inform follow-up, especially in settings where access, time, or patient condition limits other options.
A similar shift is happening in research, where imaging is no longer just a way to confirm results, but part of how questions are explored from the outset. Researchers are looking for ways to see more within a single scan — whether to differentiate materials, study fine structures, or reduce the need for destructive testing. Across both environments, the emphasis is on getting more usable information earlier, without adding steps, time, or complexity.
“Our focus has been to build technology that fits into real-world settings,” said Amol Karnick, President and CEO. “What we’re seeing now is that this approach is resonating across very different markets, including security/defense, pharmaceuticals and electric vehicles.”
Dr. Karim S. Karim, co-founder and CTO, added: “The same core technology can be applied in many contexts, from hospitals to research labs to entirely new environments. That’s where a lot of our current work is focused.”
For more information, please visit https://kaimaging.com/
July 31, 2026 
